Wendt Regional Cancer Center
Dubuque, Iowa
Delegate Rep: Andrea Watkinson
Website: unitypoint.org
Community Hospital McCook
Nebraska Delegate Rep: William Goodenkauf
Website: chmccook.org
Each year, ACCC provides members with resources and tools to strengthen their practices and programs, abundant online and in-person networking opportunities, and expert analysis of critical legislative initiatives by way of the Oncology Reimbursement Meetings (ORMs). This fall, attendees will convene in Rogers, Arkansas and Albuquerque, New Mexico to hear from industry experts on coding and billing updates, prior authorization, open enrollment, and more. Join us in November to gain strategies on navigating annual changes in oncology reimbursement and regulations and accelerate your knowledge on measures you can implement immediately to strengthen your program’s operations.
Open, effective collaboration between chimeric antigen receptor (CAR) T-cell therapy centers and referring providers is crucial to delivering the best patient care possible. To streamline communication between these stakeholders, ACCC outlines key considerations in a new, easy-to-use checklist. Quickly reference essential information that should accompany treatment summaries, such as:
To support Veterans with cancer and their families and caregivers, ACCC has curated a comprehensive collection of patient guides, research articles, videos, and tools. Explore resources that address common risk factors for Veterans, barriers to treatment, and how to navigate care through the US Department of Veterans Affairs.
Explore the stories of 3 cancer centers that participated in ACCC’s national quality improvement program to address barriers to equitable care for people living with bladder cancer. Gain actionable solutions from each program that you can apply in your own practice, such as:
Decentralized clinical trial approaches, including remote consent, telehealth, local laboratory and imaging services, and more, can help reduce some of the many barriers that prevent eligible patients from participating in trials. But as the participants in ACCC’s Advancing Decentralized Clinical Trials in the Community Setting Roundtable Series emphasized, implementing DCT elements is not simply a matter of adopting new technology. Doing so successfully requires thoughtful workflows and oversight structures that consider equity, scalability, and sustainability.
